Google
×
Feb 13, 2024 · ... Vistagen Corporate Presentation 1.8 MB. NASDAQ CM VTGN $4.01 +0.0909 (+2.32%). Data as of Mar 15, 2024 | 12:23 PM EDT. Annual Reports. Stock ...
People also ask
... VTGN $4.17 -0.04 (-0.95%). Data as of Mar 11, 2024 ... Vistagen Therapeutics, Inc. 343 Allerton Avenue South San Francisco, CA 94080. Investor Relations ...
... VTGN $4.05 +0.13 (+3.32%). Data as of Mar 15, 2024 | 4:00 PM EDT. Be the first ... Investors · Investors Overview · Stock Information · Press Releases · Events ...
Find annual and quearterly earnings data for VistaGen Therapeutics, Inc. Common Stock (VTGN) including earnings per share, earnings forecasts at Nasdaq.com.
Find the latest Vistagen Therapeutics, Inc. (VTGN) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: relations | Show results with:relations
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Feb 13, 2024 · Q3: 2024-02-13 Earnings Summary · Mark McPartland - Senior Vice President, Investor Relations · Andrew Tsai - Jefferies · Greetings and welcome to ...
Rating (975)
VistaGen Therapeutics (VTGN) will release its next earnings report on Jun 24, 2024 ... investors and does not represent returns that any investor actually ...
Missing: relations | Show results with:relations
The Investor Relations website contains information about Vistagen Therapeutics, Inc's business for stockholders, potential investors, and financial analysts.
Senior Vice President of Investor Relations, 300k, N/A, 1966. Ms. Trisha Fitzmaurice, Senior Vice President of Human Resources, N/A, N/A, N/A. Dr. Allen Easley ...